CYP27A1 and breast cancer: Likewise, the average risk of dying specifically due to a BC-related cause remained elevated by about 40% for all patients and between 60 and 70% for ER+ patients with high CYP27A1 compared to low CYP27A1 tumors, although the evidence was weaker statistically (Supplementary Table 3).